UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Linde
LIN
|
+$786M |
| 3 |
Energy Transfer Partners
ET
|
+$666M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$445M |
| 5 |
UBS Group
UBS
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.06B |
| 2 |
Colgate-Palmolive
CL
|
+$665M |
| 3 |
PX
Praxair Inc
PX
|
+$528M |
| 4 |
Apple
AAPL
|
+$503M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.03% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.26% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
TG Therapeutics
TGTX
$7.6B
| $1.49M | ﹤0.01% |
364,383
+323,887
| +800% | +$1.61M |
|
3302
Workiva
WK
$3.53B
| $1.49M | ﹤0.01% |
41,626
+16,164
| +63% | +$568K |
|
|
SAND
3303
DELISTED
Sandstorm Gold
SAND
| $1.49M | ﹤0.01% |
323,916
-719,229
| -69% | -$2.92M |
|
3304
Diana Shipping
DSX
$299M
| $1.49M | ﹤0.01% |
671,380
+106,681
| +19% | +$268K |
|
3305
Mesa Laboratories
MLAB
$572M
| $1.49M | ﹤0.01% |
7,149
+467
| +7% | +$91.1K |
|
|
MQT
3306
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $1.49M | ﹤0.01% |
130,259
-26,093
| -17% | -$297K |
|
3307
Westlake Corp
WLK
$10B
| $1.49M | ﹤0.01% |
22,474
-61,473
| -73% | -$4.44M |
|
3308
Invesco DB Oil Fund
DBO
$370M
| $1.49M | ﹤0.01% |
175,244
+3,389
| +2% | +$37.6K |
|
3309
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$365M
| $1.48M | ﹤0.01% |
53,833
+11,828
| +28% | +$349K |
|
3310
Performance Food Group
PFGC
$18B
| $1.48M | ﹤0.01% |
45,922
+36,375
| +381% | +$1.15M |
|
3311
Dentsply Sirona
XRAY
$2.42B
| $1.48M | ﹤0.01% |
39,817
-44,034
| -53% | -$1.6M |
|
3312
TD Synnex
SNX
$20.4B
| $1.48M | ﹤0.01% |
36,570
+11,662
| +47% | +$462K |
|
|
AMAG
3313
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.48M | ﹤0.01% |
97,256
+57,440
| +144% | +$1.09M |
|
3314
Grand Canyon Education
LOPE
$3.96B
| $1.48M | ﹤0.01% |
15,354
-7,086
| -32% | -$824K |
|
3315
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.1M
| $1.48M | ﹤0.01% |
78,054
-330,403
| -81% | -$6.72M |
|
3316
Schwab International Small-Cap Equity ETF
SCHC
$5.65B
| $1.47M | ﹤0.01% |
50,641
+7,287
| +17% | +$232K |
|
3317
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$717M
| $1.47M | ﹤0.01% |
23,615
+3,121
| +15% | +$194K |
|
3318
Rayonier
RYN
$6.51B
| $1.47M | ﹤0.01% |
58,620
+19,710
| +51% | +$546K |
|
3319
iShares MSCI Sweden ETF
EWD
$595M
| $1.47M | ﹤0.01% |
52,058
+14,380
| +38% | +$422K |
|
3320
Oaktree Specialty Lending
OCSL
$1.15B
| $1.47M | ﹤0.01% |
115,798
-102,193
| -47% | -$1.4M |
|
|
UCB
3321
United Community Banks
UCB
$4.29B
| $1.47M | ﹤0.01% |
68,504
+7,947
| +13% | +$196K |
|
|
ETO
3322
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$519M
| $1.47M | ﹤0.01% |
78,185
-760
| -1% | -$16.5K |
|
|
BWG
3323
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$130M
| $1.47M | ﹤0.01% |
141,257
-22,097
| -14% | -$230K |
|
|
CS
3324
PUT
DELISTED
Credit Suisse Group
CS
| $1.47M | ﹤0.01% |
+135,000
| New | +$1.67M |
|
3325
Capitol Federal Financial
CFFN
$1.1B
| $1.47M | ﹤0.01% |
114,789
+8,136
| +8% | +$105K |
|
Similar funds
UBS Group's Q4 2018 Portfolio in Review
As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
- UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
- UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
- UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
- UBS Group opened 731 new positions and closed 648 in Q4 2018.
- UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.